Rensoti (ivermectin/oxymetazoline HCl/niacinamide)
Acne Products Topical Cream (Gram)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Generic name: ivermectin/oxymetazoline HCl/niacinamide
Drug class: Acne Products
Therapeutic class: Dermatological
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Rensoti
Indications
No indications are available for this drug.
Dosing
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
- Angle-closure glaucoma
There are no severe contraindications for this drug.
- Coronary artery disease
- Hypertension
- No disease contraindications
- Orthostatic hypotension
- Raynaud's phenomenon
- Sjogren's syndrome
Adverse reactions
There is no enhanced messaging for this drug.
Rare or Very Rare
- Allergic dermatitis
- Dyspnea
- Ocular irritation
- Skin rash
Less Frequent
- Erythema
- Pain
- Pruritus of skin
- Skin inflammation
Rare or Very Rare
- Conjunctival hyperemia
- Contact dermatitis
- Dandruff
- Dry skin
- Ocular redness
- Skin irritation
- Stinging of skin
- Treatment site sequelae
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.